Saad Z. Usmani, MD, MBA, FACP / Gareth J. Morgan, MD, PhD - Strength in Numbers: Triplet Combination Therapies in Relapsed/Refractory Multiple Myeloma (RRMM) Special Patient Populations

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NHL Metropolitan Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 11PM EDT 5 min · 25 Sep 2026 · NPR News Now

We're Going Back To Mortis? 'Ahsoka' Season 2 Details Revealed! | The SWU Podcast LIVE 1h 39m · 25 Sep 2026 · The Star Wars Underworld Podcast

Microsoft AI Boss: “A Silicon Species” Could Compete With HumansMicrosoft AI Boss: “A Silicon Species” Could Compete With Humans 38 min · 25 Sep 2026 · AI Haven't A Clue

Who are the "passport bros" travelling abroad to find love? 5 min · 25 Sep 2026 · Do you really know?

Can plate colour really affect our sense of taste? 5 min · 25 Sep 2026 · Do you really know?

Report any issue

Source

Recorded07 Jul 2023

Publisherc.answersincme.com ↗

Handlerec:10296355

Show notes

Please visit answersincme.com/MMD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts in multiple myeloma discuss triplet combination therapies and treatment selection in relapsed/refractory multiple myeloma (RRMM). Upon completion of this activity, participants should be better able to: Explain current guideline recommendations to optimize clinical treatment plans for patients with RRMM; Review the clinical implications of the latest data for triplet regimens containing an anti-CD38 monoclonal antibody, proteasome inhibitors, and chemotherapy in special patient populations with RRMM; and Identify additional monitoring strategies for special patient subgroups with RRMM based on the latest clinical evidence and expert guidance.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in